[1]
Amna Rizwan et al. 2022. Factors affecting the visual outcomes and central macular thickness in diabetic maculopathy after intravitreal bevacizumab. Journal of the Pakistan Medical Association. 72, 11 (Dec. 2022), 2213–2217. DOI:https://doi.org/10.47391/JPMA.4729.